Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.
Financial Results:
Unichem Laboratories Ltd reported Revenues for Q3FY24 of ₹434.00 Crores up from ₹302.00 Crore year on year, a rise of 43.71%.
Total Expenses for Q3FY24 of ₹430.00 Crores up from ₹380.00 Crores year on year, a rise of 13.16%.
Consolidated Net Profit of ₹84.00 Crores from -₹64.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.93, from -₹9.08 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.